To evaluate three months follow-up of SING IMT implant in patients affected by late-stage AMD
Design
Prospective cohort study
Subjects
In a total of 80 eyes of 40 patients who underwent the enrollment tests, 11 patients’ eyes affected by late-stage AMD matched the inclusion criteria and underwent SING IMT implant from February to June 2022.
Methods
Before surgery, each patient underwent the enrollment examination to verify inclusion and exclusion criteria.
Main outcome measures
BCVA for distance and for near, IOP, ACD and ECD were evaluated at 1 and 3 months follow up. Also quality of life in doing the activities of daily life was evaluated.
Results
BCVA for distance and for near improved from baseline to 3 months follow up (23.91 ± 9.418 ETDRS letters and 59.09 ± 11.58 ETDRS letters respectively (p < 0.001). An endothelial cell loss was shown (p < 0.001), with a rate of cell density reduction around 8.3% (baseline vs 3 months).
Conclusions
SING IMT could be a valid surgical device to improve patients’ sight and quality of life which have been deteriorated by late-stage macular degeneration. Further studies with more patients and longer follow up are needed to confirm our results.
WongWLSuXLiX, et al.Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Heal2014; 2: e106–e116. doi:https://doi.org/10.1016/S2214-109X(13)70145-1
2.
ClemonsTEMiltonRCKleinR, et al.Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS)AREDS report no. 19. Ophthalmology2005; 112: 533–539. doi:https://doi.org/10.1016/j.ophtha.2004.10.047
ChakravarthyUWongTYFletcherA, et al.Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol2010; 10: 31. doi:https://doi.org/10.1186/1471-2415-10-31
6.
DavisMDGangnonRELeeLY, et al.Age-Related eye disease study group. The age-related eye disease study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol2005;123:1484–1498[Erratum in: Arch Ophthalmol. 2006;124(2):289-90]. doi:https://doi.org/10.1001/archopht.123.11.1484
SingerMAAmirNHerroA, et al.Improving quality of life in patients with end-stage age-related macular degeneration: focus on miniature ocular implants. Clin Ophthalmol2012; 6: 33–39.
9.
GrzybowskiAWangJMaoF,et al.Intraocular vision-improving devices in age-related macular degeneration. Ann Transl Med. 2020 Nov;8:1549. doi:https://doi.org/10.21037/atm-20-5851
10.
BorkensteinAFBorkensteinEMAugustinAJ. Implantable vision-enhancing devices and postoperative rehabilitation in advanced age-related macular degeneration. Eye (Lond)2022 Jul 22: 597–606.
11.
SavastanoACaporossiTSassoP, et al.A new intraocular telescopic device for age-related macular degeneration. Ophthalmol Retina2022; S2468- 6530: 00251–2.
12.
WolffsohnJSCochraneAL. Design of the low vision quality-of-life questionnaire (LVQOL) and measuring the outcome of low-vision rehabilitation. Am J Ophthalmol. 2000 Dec;130:793–802. doi: https://doi.org/10.1016/s0002-9394(00)00610-3. PMID: 11124300
13.
DoddsAGBaileyPPearsonA,et al.Psychological factors in acquired visual impairment: the development of a scale of adjustment. J Vis Impairment1991; 85: 306–310. doi:https://doi.org/10.1177/0145482X9108500711
14.
GrzybowskiAWasinska-BorowiecWAlioJL, et al.Intraocular lenses in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol2017; 255: 1687–1696. doi:https://doi.org/10.1007/s00417-017-3740-8
15.
DunbarHMPDhawahir-ScalaFE. A discussion of commercially available intra-ocular telescopic implants for patients with age-related macular degeneration. Ophthalmol Ther2018; 7: 33–48. doi:https://doi.org/10.1007/s40123-018-0129-7
LaneSSKuppermannBDFineIH, et al.A prospective multicenter clinical trial to evaluate the safety and effectiveness of the implantable miniature telescope. Am J Ophthalmol. 2004 Jun;137:993–1001. doi:https://doi.org/10.1016/j.ajo.2004.01.030
18.
HudsonHLLaneSSHeierJS, et al.Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results. Ophthalmol2006; 113: 1987–2001. doi:https://doi.org/10.1016/j.ophtha.2006.07.010
19.
HudsonHLStultingRDHeierJS, et al.Implantable telescope for end-stage age-related macular degeneration: long- term visual acuity and safety outcomes. Am J Ophthalmol2008; 146: 664–673. doi:https://doi.org/10.1016/j.ajo.2008.07.003
20.
oyerDFreundKBRegilloC, et al.Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration. Clin Ophthalmol2015; 9: 1099–1107.
21.
RichardJHoffartLChavaneF,et al.Corneal endothelial cell loss after cataract extraction by using ultrasound phacoemulsification versus a fluid-based system. Cornea. 2008 Jan;27:17–21. doi:https://doi.org/10.1097/ICO.0b013e3181583115
